129 related articles for article (PubMed ID: 16858234)
1. Tumour markers in chronic heart failure. Review of the literature and clinical implications.
Faggiano P; D'Aloia A; Antonini-Canterin F; Vizzardi E; Nicolosi GL; Cas LD
J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):573-9. PubMed ID: 16858234
[TBL] [Abstract][Full Text] [Related]
2. Relationship between cytokines and tumour markers in patients with chronic heart failure.
Kosar F; Aksoy Y; Ozguntekin G; Ozerol I; Varol E
Eur J Heart Fail; 2006 May; 8(3):270-4. PubMed ID: 16309955
[TBL] [Abstract][Full Text] [Related]
3. One biologic marker (carbohydrate antigen-CA 125), two different diseases (ovarian cancer and congestive heart failure): practical implications of monitoring CA 125 serum levels. A case report.
Faggiano P; D'Aloia A; Bignotti T; Dei Cas L
Ital Heart J; 2003 Jul; 4(7):497-9. PubMed ID: 14558304
[TBL] [Abstract][Full Text] [Related]
4. Estimation of CA 125 concentration in patients with congestive heart failure.
Skórzyńska H; Solski J; Gernand W; Matras P; Gniwek M; Sokół M
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):261-4. PubMed ID: 16145993
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrate antigen 125: a new biomarker in heart failure.
Vizzardi E; D'Aloia A; Curnis A; Dei Cas L
Cardiol Rev; 2013; 21(1):23-6. PubMed ID: 22735832
[TBL] [Abstract][Full Text] [Related]
6. Tumour biomarkers in heart failure: is there a role for CA-125?
Yilmaz MB; Nikolaou M; Cohen Solal A
Eur J Heart Fail; 2011 Jun; 13(6):579-83. PubMed ID: 21525015
[TBL] [Abstract][Full Text] [Related]
7. CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure.
Vizzardi E; Nodari S; D'Aloia A; Chiari E; Faggiano P; Metra M; Dei Cas L
Echocardiography; 2008 Oct; 25(9):955-60. PubMed ID: 18771557
[TBL] [Abstract][Full Text] [Related]
8. The tumor marker CA-125 and heart failure.
Miñana G; Palau P; Núñez J; Sanchis J
Rev Esp Cardiol; 2010 Oct; 63(10):1213-4. PubMed ID: 20875366
[No Abstract] [Full Text] [Related]
9. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
Gadducci A; Tana R; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
[TBL] [Abstract][Full Text] [Related]
10. Tumour marker levels in patients with chronic heart failure.
Varol E; Ozaydin M; Dogan A; Kosar F
Eur J Heart Fail; 2005 Aug; 7(5):840-3. PubMed ID: 15916923
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate antigen-125: additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome.
De Gennaro L; Brunetti ND; Bungaro R; Montrone D; Cuculo A; Pellegrino PL; Correale M; Di Biase M
Coron Artery Dis; 2009 Jun; 20(4):274-80. PubMed ID: 19440066
[TBL] [Abstract][Full Text] [Related]
12. CA125 levels among patients with advanced heart failure: an emerging independent predictor for survival.
Turgut O; Tandogan I; Yilmaz MB; Gul I; Gurlek A
Int J Cardiol; 2010 Nov; 145(1):71. PubMed ID: 19446349
[TBL] [Abstract][Full Text] [Related]
13. Serum tumour markers in patients with chronic kidney disease.
Xiaofang Y; Yue Z; Xialian X; Zhibin Y
Scand J Clin Lab Invest; 2007; 67(6):661-7. PubMed ID: 17852811
[TBL] [Abstract][Full Text] [Related]
14. Significance of serum tumor markers carcinoembryonic antigen, CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation.
Pissaia A; Bernard D; Scatton O; Soubrane O; Conti F; Calmus Y
Transplant Proc; 2009 Mar; 41(2):682-4. PubMed ID: 19328956
[TBL] [Abstract][Full Text] [Related]
15. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry.
Assmus B; Fischer-Rasokat U; Honold J; Seeger FH; Fichtlscherer S; Tonn T; Seifried E; Schächinger V; Dimmeler S; Zeiher AM;
Circ Res; 2007 Apr; 100(8):1234-41. PubMed ID: 17379833
[TBL] [Abstract][Full Text] [Related]
16. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.
Antonini-Canterin F; Popescu BA; Popescu AC; Beladan CC; Korcova R; Piazza R; Cappelletti P; Rubin D; Cassin M; Faggiano P; Nicolosi GL
Int J Cardiol; 2008 Aug; 128(3):406-12. PubMed ID: 17662495
[TBL] [Abstract][Full Text] [Related]
17. Serum carbohydrate antigen 125 has prognostic significance in heart failure, but no implications on treatment.
Beton O; Yucel O
Int J Cardiol; 2011 Sep; 151(2):241. PubMed ID: 21724271
[No Abstract] [Full Text] [Related]
18. [New tumour markers useful in diagnostics and monitoring of cervical cancer].
Bedkowska GE; Lawicki S; Szmitkowski M
Przegl Lek; 2007; 64(12):1022-7. PubMed ID: 18595508
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for chronic heart failure.
Lainscak M; von Haehling S; Springer J; Anker SD
Heart Fail Monit; 2007; 5(3):77-82. PubMed ID: 17487296
[TBL] [Abstract][Full Text] [Related]
20. Value of tumour and inflammatory markers in lung cancer.
Oremek GM; Sauer-Eppel H; Bruzdziak TH
Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]